Phage Display Technology
Phage Display Technology Overview
Phage display technology is a versatile approach that relies on the genetic modification of bacteriophages to present foreign proteins on their capsid surfaces. This technology has gained widespread popularity in antibody-antigen research due to its simplicity, convenience, speed, and cost-effectiveness. KYinno has developed a human naïve Fab library that harnesses the power of phage display. This library offers a broad spectrum of specificities and is readily amenable to panning with various antigens, including those with low immunogenicity or high toxicity levels that would be unsuitable for traditional immunization. Moreover, leveraging a pre-established mouse model, we can generate VHH, scFv, or Fab libraries post-immunization, catering to the diverse antibody screening needs of our clients.
All Antibody Discovery Services
Hybridoma technology is the bedrock of antibody discovery, merging immunized cells to generate monoclonal antibodies. This ensures consistency, high specificity, and high yield for therapeutic and diagnostic applications.
Single B cell screening represents a breakthrough in antibody discovery. Using state-of-the-art technology to isolate, sequence, and analyze individual B cells, ensuring precise identification of specific antibodies for novel treatments.
Utilizing advanced biotechnology, our engineered bispecific antibodies bind two distinct targets. This innovation has the potential to revolutionize therapeutic strategies, heightening specificity, expanding treatment options, and paving the way for future medical advancements.
